Clinical Trial Update: A Phase 2, Randomized, Double Blind, Placebo Controlled Study of AMG 386 in Combination With FOLFIRI in Subjects With Previously Treated Metastatic Colorectal Carcinoma [Phase 2]

View source ↗

Summary

A Phase 2 randomized study evaluating AMG 386 in combination with FOLFIRI in previously treated metastatic colorectal cancer has completed; efficacy and safety …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colon Cancer
• Colorectal Cancer
• Rectal Cancer

Drugs mentioned

• 5-Fluorouracil (5-FU)
• AMG-386 (trebananib)
• Irinotecan (Irinotecan)
• Leucovorin (folinic acid)

Snippet

Sponsor: Amgen | Conditions: Cancer, Carcinoma | Phase 2 | Status: COMPLETED